• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

J.H. Whitney Announces the Sale of Accupac

Share:

January 27, 2020

J.H. Whitney Capital Partners, LLC, a leading private equity investment firm, is pleased to announce the sale of its portfolio company Accupac, Inc. (“Accupac” or the “Company”) to Palladium Equity Partners.

Accupac is a leading U.S. provider of outsourced manufacturing and packaging solutions to the world’s largest personal care product, pharmaceutical, and over-the-counter (OTC) drug manufacturers. The Company is a specialist in liquid topical and oral care products, including skin creams, toothpastes, moisturizing lotions, mouthwash and other personal care products, many of which require FDA approval. All Accupac manufacturing facilities are FDA registered and cGMP compliant.

Through J.H. Whitney’s partnership with Accupac’s leadership team, the Company made significant improvements in both operations and sales. During J.H. Whitney’s investment period, Accupac implemented facility improvements to substantially increase and expand manufacturing capacity. Furthermore, the Company has driven significant organic growth with new and existing customers given Accupac’s unique ability to manufacture specialty products.

Bruce Wright, Accupac’s CEO, said, “We are proud of what we accomplished during our partnership with J.H. Whitney and we are excited to continue Accupac’s growth trajectory with our new partner Palladium Equity Partners. We believe that this transaction is the right step for Accupac to continue offering our customers superior quality products.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We have had a great partnership with the Accupac management team and we are proud of the changes made to further position the Company for success,” commented Bob Williams, a Senior Managing Director at J.H. Whitney. “Through substantial investment in people and facilities, with a constant focus on customers, Accupac has developed into a market leader. We look forward to seeing Accupac continue its successful growth with Palladium.”

Bob Williams and Aaron Pomeroy led the transaction for J.H. Whitney. Lincoln International, LLC served as financial advisor to Accupac on the transaction. Gibson, Dunn & Crutcher LLP served as the Company’s legal advisors. Houlihan Lokey served as financial advisor for Palladium. Greenberg Traurig, LLP served as the legal advisors for Palladium.

The transaction terms were not disclosed.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • To deploy AI tech, healthcare needs to first be data literateTo deploy AI tech, healthcare needs to first be data literate
  • Cone Health Launches Innovation Center to Develop & Launch IdeasCone Health Launches Innovation Center to Develop & Launch Ideas
  • Innovators Share Tech, Ideas on Treating the CoronavirusInnovators Share Tech, Ideas on Treating the Coronavirus
  • Horizon Therapeutics Shareholders Overwhelmingly Approve the Acquisition By AmgenHorizon Therapeutics Shareholders Overwhelmingly Approve the Acquisition By Amgen
  • Biotech Giants Merge | Akari and Peak Unite ForcesBiotech Giants Merge | Akari and Peak Unite Forces
  • Select Medical Signs Agreement to Acquire Vibra Hospital of RichmondSelect Medical Signs Agreement to Acquire Vibra Hospital of Richmond
  • Portage announces setting of meeting date to approve SalvaRx acquisitionPortage announces setting of meeting date to approve SalvaRx acquisition
  • There’s a Huge Problem With the Core of the Human Genome ProjectThere’s a Huge Problem With the Core of the Human Genome Project

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications